Klermund Julia, Rhiel Manuel, Kocher Thomas, Chmielewski Kay Ole, Bischof Johannes, Andrieux Geoffroy, El Gaz Melina, Hainzl Stefan, Boerries Melanie, Cornu Tatjana I, Koller Ulrich, Cathomen Toni
Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg, 79106 Freiburg, Germany; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, 79106 Freiburg, Germany.
EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.
Mol Ther. 2024 May 1;32(5):1298-1310. doi: 10.1016/j.ymthe.2024.03.006. Epub 2024 Mar 7.
Undesired on- and off-target effects of CRISPR-Cas nucleases remain a challenge in genome editing. While the use of Cas9 nickases has been shown to minimize off-target mutagenesis, their use in therapeutic genome editing has been hampered by a lack of efficacy. To overcome this limitation, we and others have developed double-nickase-based strategies to generate staggered DNA double-strand breaks to mediate gene disruption or gene correction with high efficiency. However, the impact of paired single-strand nicks on genome integrity has remained largely unexplored. Here, we developed a novel CAST-seq pipeline, dual CAST, to characterize chromosomal aberrations induced by paired CRISPR-Cas9 nickases at three different loci in primary keratinocytes derived from patients with epidermolysis bullosa. While targeting COL7A1, COL17A1, or LAMA3 with Cas9 nucleases caused previously undescribed chromosomal rearrangements, no chromosomal translocations were detected following paired-nickase editing. While the double-nicking strategy induced large deletions/inversions within a 10 kb region surrounding the target sites at all three loci, similar to the nucleases, the chromosomal on-target aberrations were qualitatively different and included a high proportion of insertions. Taken together, our data indicate that double-nickase approaches combine efficient editing with greatly reduced off-target effects but still leave substantial chromosomal aberrations at on-target sites.
CRISPR-Cas核酸酶产生的意外的靶向和脱靶效应仍然是基因组编辑中的一个挑战。虽然使用Cas9切口酶已被证明可将脱靶诱变降至最低,但它们在治疗性基因组编辑中的应用因缺乏有效性而受到阻碍。为了克服这一限制,我们和其他人开发了基于双切口酶的策略,以产生交错的DNA双链断裂,从而高效介导基因破坏或基因校正。然而,配对单链切口对基因组完整性的影响在很大程度上仍未得到探索。在这里,我们开发了一种新颖的CAST-seq流程,即双重CAST,以表征由配对的CRISPR-Cas9切口酶在源自大疱性表皮松解症患者的原代角质形成细胞的三个不同位点诱导的染色体畸变。虽然用Cas9核酸酶靶向COL7A1、COL17A1或LAMA3会导致先前未描述的染色体重排,但在配对切口酶编辑后未检测到染色体易位。虽然双切口策略在所有三个位点的靶位点周围10 kb区域内诱导了大片段缺失/倒位,类似于核酸酶,但染色体上的靶向畸变在性质上有所不同,并且包括高比例的插入。综上所述,我们的数据表明,双切口酶方法将高效编辑与大大降低的脱靶效应相结合,但仍会在靶位点留下大量染色体畸变。